Patents by Inventor Rocco Dean Gogliotti

Rocco Dean Gogliotti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidines as inhibitors of phosphoinositide-3-kinases (PI3K)
    Publication number: 20090227587
    Abstract: The present invention provides pyrimidines of Formula I: wherein R4, R6, and Y have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cardiovascular diseases, and cancers. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I.
    Type: Application
    Filed: October 19, 2004
    Publication date: September 10, 2009
    Inventors: Michael Kevin Connolly, Rocco Dean Gogliotti, Mark Stephen Plummer, Melean Visnick
  • Pyrrolyl Substituted Pyrido[2,3-D]Pyrimidin-7-Ones and Derivatives Thereof as Therapeutic Agents
    Publication number: 20080255162
    Abstract: The present invention provides pyrimidines of Formula I: wherein R2, R4, R5, R6, R8 and J have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases, including inflammatory diseases, cardiovascular diseases, and cancers. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I.
    Type: Application
    Filed: April 22, 2005
    Publication date: October 16, 2008
    Inventors: Michelle Marie Bruendl, Rocco Dean Gogliotti, Annise Paige Goodman, Gregory Adam Reichard
  • 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
    Publication number: 20040259926
    Abstract: The present invention provides benzo[b]thiophenes of Formula I: 1
    Type: Application
    Filed: June 3, 2004
    Publication date: December 23, 2004
    Inventors: Michelle M. Bruendl, Michael Connolly, Annise Paige Goodman, Rocco Dean Gogliotti, Helen Tsenwhei Lee, Mark Stephen Plummer, Karen Elaine Sexton, Aurash B. Shahripour, Greg Reichard, Melean Visnick, Michael William Wilson
  • Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
    Publication number: 20040248954
    Abstract: The present invention provides benzo[b]thiophenes of Formula I: 1
    Type: Application
    Filed: June 3, 2004
    Publication date: December 9, 2004
    Inventors: Rocco Dean Gogliotti, Helen Tsenwhei Lee, Karen Elaine Sexton, Melean Visnick
  • 3-Arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
    Publication number: 20040248953
    Abstract: The present invention provides benzo[b]thiophenes of Formula I: 1
    Type: Application
    Filed: June 3, 2004
    Publication date: December 9, 2004
    Inventors: Rocco Dean Gogliotti, Helen Tsenwhei Lee, Karen Elaine Sexton, Melean Visnick
  • Benzoxazines and derivatives thereof as therapeutic agents
    Publication number: 20040138199
    Abstract: The present invention provides compounds of Formula I 1
    Type: Application
    Filed: December 22, 2003
    Publication date: July 15, 2004
    Inventors: Rocco Dean Gogliotti, Keri Lynn Muccioli, Kimberly Suzanne Para, Melean Visnick
  • Diazepinones as antiviral agents
    Publication number: 20040116410
    Abstract: The invention is novel compounds of formula (I) which exhibit an improved therapeutic index and improved metabolic stability which are useful in the treatment and/or prevention of herpes viral infections. Novel intermediates useful in the synthesis of the final compounds are also part of the invention.
    Type: Application
    Filed: February 18, 2003
    Publication date: June 17, 2004
    Inventors: Hidetsura Cho, Rocco Dean Gogliotti, Harriet Wall Hamilton, Alexei Krasutsky, Takeshi Nakamura, Hiroki Tada, Peter Craig Weber
  • Isothiazolones and pharmaceutical formulations
    Patent number: 6133270
    Abstract: Isothiazolones having the general structure ##STR1## where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R.sup.1 and R.sup.2 are substituent groups such as alkyl, alkoxy, hydroxy, nitro, cyano, amino, and carboxy; and R.sup.5 is alkyl, cycloalkyl, phenyl, and Het. The isothiazolones are useful as anti-retroviral agents, anti-inflammatory agents, and anti-atherosclerotic agents.
    Type: Grant
    Filed: June 26, 1997
    Date of Patent: October 17, 2000
    Assignee: Warner-Lambert Company
    Inventors: Gary Louis Bolton, John Michael Domagala, Edward Faith Elslager, Rocco Dean Gogliotti, Terri Stoeber Purchase, Joseph Peter Sanchez, Bharat Kalidas Trivedi
  • Isothiazolones
    Patent number: 6001863
    Abstract: Isothiazolones having the general structure ##STR1## where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R.sup.1 and R.sup.2 are substituent groups such as alkyl, alkoxy, hydroxy, nitro, cyano, amino, and carboxy; and R.sup.5 is alkyl, cycloalkyl, phenyl, and Het. The isothiazolones are useful as anti-retroviral agents, anti-inflammatory agents, and anti-atherosclerotic agents.
    Type: Grant
    Filed: June 26, 1997
    Date of Patent: December 14, 1999
    Assignee: Warner-Lambert Company
    Inventors: Gary Louis Bolton, John Michael Domagala, Edward Faith Elslager, Rocco Dean Gogliotti, Terri Stoeber Purchase, Joseph Peter Sanchez, Bharat Kalidas Trivedi
  • Arylthio compounds
    Patent number: 5929114
    Abstract: Arylthiol and dithiobisarylamide antibacterial and antiviral agents have the general formula ##STR1## where A is monocyclic or bicyclic aryl which can contain up to 3 heteroatoms selected from O, S, and N,R.sup.1 and R.sup.2 are substituent groups, X is ##STR2## or SO.sub.2 NR.sup.4 Z, Y is H or SZ when n is 1, a single bond when n is 2; R.sup.4 and Z can be hydrogen or alkyl.
    Type: Grant
    Filed: May 15, 1997
    Date of Patent: July 27, 1999
    Assignee: Warner-Lambert Company
    Inventors: John Michael Domagala, Edward Faith Elslager, Rocco Dean Gogliotti
  • Isothiazolones
    Patent number: 5889034
    Abstract: Isothiazolones having the general structure ##STR1## where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R.sup.1 and R.sup.2 are substituent groups such as alkyl, alkoxy, hydroxy, nitro, cyano, amino, and carboxy; and R.sup.5 is alkyl, cycloalkyl, phenyl, and Het. The isothiazolones are useful as anti-retroviral agents, anti-inflammatory agents, and anti-atherosclerotic agents.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: March 30, 1999
    Assignee: Warner-Lambert Company
    Inventors: Gary Louis Bolton, John Michael Domagala, Edward Faith Elslager, Rocco Dean Gogliotti, Terri Stoeber Purchase, Joseph Peter Sanchez, Bharat Kalidas Trivedi
  • Isothiazolone compounds
    Patent number: 5733921
    Abstract: Isothiazolones having the general structure ##STR1## where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R.sup.1 and R.sup.2 are substituent groups such as alkyl, alkoxy, hydroxy, nitro, cyano, amino, and carboxy; and R.sup.5 is alkyl, cycloalkyl, phenyl, and Het. The isothiazolones are useful as anti-retroviral agents, anti-inflammatory agents, and anti-atherosclerotic agents.
    Type: Grant
    Filed: November 26, 1996
    Date of Patent: March 31, 1998
    Assignee: Warner-Lambert Company
    Inventors: Gary Louis Bolton, John Michael Domagala, Edward Faith Elslager, Rocco Dean Gogliotti, Terri Stoeber Purchase, Joseph Peter Sanchez, Bharat Kalidas Trivedi
  • Arylthio compounds
    Patent number: 5734081
    Abstract: Arylthiol and dithiobisarylamide antibacterial and antiviral agents have the general formula ##STR1## where A is monocyclic or bicyclic aryl which can contain up to 3 heteroatoms selected from O, S, and N,R.sup.1 and R.sup.2 are substituent groups, X is ##STR2## or SO.sub.2 NR.sup.4 Z, Y is H or SZ when n is 1, a single bond when n is 2; R.sup.4 and Z can be hydrogen or alkyl.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: March 31, 1998
    Assignee: Warner-Lambert Company
    Inventors: John Michael Domagala, Edward Faith Elslager, Rocco Dean Gogliotti
  • Arylthio compounds
    Patent number: 5668291
    Abstract: Arylthiol and dithiobisarylamide antibacterial and antiviral agents have the general formula ##STR1## where A is monocyclic or bicyclic aryl which can contain up to 3 heteroatoms selected from O, S, and N, R.sup.1 and R.sup.2 are substituent groups, X is ##STR2## or SO.sub.2 NR.sup.4 Z, Y is H or SZ when n is 1, a single bond when n is 2; R.sup.4 and Z can be hydrogen or alkyl.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 16, 1997
    Assignee: Warner-Lambert Company
    Inventors: John Michael Domagala, Edward Faith Elslager, Rocco Dean Gogliotti
  • Arylthio compounds
    Patent number: 5668178
    Abstract: Phenylthiols and dithiobisbenzamides are potent antibacterial and antiviral agents.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: September 16, 1997
    Assignee: Warner-Lambert Company
    Inventors: Edward Faith Elslager, Rocco Dean Gogliotti